What is Retatrutide?

The triple acting peptide changing the fat loss game.

What is Retatrutide?

Retatrutide is a breakthrough peptide that activates GLP-1, GIP, and glucagon receptors—making it one of the most advanced compounds for fat loss and metabolic control.

Most popular weight loss injections (like Ozempic) only target GLP-1. Retatrutide targets three fat-burning pathways at once.

In clinical trials, subjects experienced an average weight loss of 24.2% over 12–18 weeks—outperforming Ozempic, Wegovy, and Mounjaro.

What to Expect

  • Reduced appetite in 7–10 days

  • Better insulin sensitivity

  • Decreased cravings

  • Mild side effects (nausea, constipation, dry mouth) often fade quickly

Why It’s Different

✅ Triple-action targeting (GLP-1, GIP, Glucagon)
✅ Stronger outcomes in clinical trials
✅ Better tolerance profile
✅ Once-a-week dosing
✅ Available for research use via Zempra Labs

Want to begin your research cycle?
Visit our Starter Pack & Pricing page to place your first order.